Moreover, we cannot rule out the possibility that circulating SSEA-1+ cells express CXCR7 and compete for/exhaust binding of CXCL12, thereby decreasing airway inflammation and maintaining the epithelial barrier in asthma. Here, CXCL12 is linked to asthma.